Bohnen Shane 4/A
4/A · BIO-TECHNE Corp · Filed Dec 14, 2023
Insider Transaction Report
Form 4/AAmended
BIO-TECHNE CorpTECH
Bohnen Shane
SVP - General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2023-08-15+12,924→ 12,924 totalExercise: $84.61Exp: 2030-08-15→ Common Stock (12,924 underlying) - Award
Restricted Stock Units
2023-08-15+4,802→ 4,802 total→ Common Stock (4,802 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F2]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).